SK PHARMTECO
LIVE

Serial Number

88740759

Owner

SK INC.

Attorney

Hun Joon Kim

Filing Date

Dec 27, 2019

Add to watchlist:

No watchlists yet
View on USPTO

SK PHARMTECO Trademark

Serial Number: 88740759 • Registration: 6269493

SK PHARMTECO is a trademark filed by SK INC. on December 27, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SK INC.

26, JONG-RO, JONGNO-GU
SEOUL 03188 , KR

Entity Type: 03

SK HOLDINGS CO., LTD

Seoul 03188 , KR

Entity Type: 03

Trademark Details

Filing Date

December 27, 2019

Registration Date

February 16, 2021

Published for Opposition

December 1, 2020

Goods & Services

Pharmaceutical and veterinary preparations for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; dietetic food supplements, namely, dietetic foods adapted for medical purposes, dietetic food adapted for veterinary use; sanitary preparations for medical purposes; biological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; Preparations of trace elements for human and animal use, namely, nutritional supplements; ferments for pharmaceutical purposes; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; blood solvent, namely, blood plasma, albumin, globulin, fibrinogen, thrombocyte and platelets; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for sanitary use; Pharmaceutical preparations, namely, immunomodulators; vitamin preparations; vaccines; Dietary and nutritional supplements; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; bacteriological preparations for medical and veterinary use

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 16, 2026 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 6, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 6, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 6, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 6, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 6, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 6, 2024 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 7, 2021 ASGN
REGISTERED-PRINCIPAL REGISTER
Feb 16, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 1, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 1, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 11, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 24, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 9, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2020 CRFA
ASSIGNED TO LIE
Oct 3, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 28, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 22, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 22, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 22, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 7, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 4, 2020 NWOS
NEW APPLICATION ENTERED
Dec 31, 2019 NWAP